Insider Selling: IBEX (NASDAQ:IBEX) CEO Sells $225,100.00 in Stock

Key Points

  • IBEX CEO Robert Dechant sold 5,000 shares at an average price of $45.02, totaling $225,100. The Rule 10b5-1 transaction reduced his ownership by 1.91%, leaving him with 257,011 shares; he also sold 25,000 shares earlier in September.
  • IBEX’s latest quarterly results slightly exceeded expectations, with EPS of $0.85 versus $0.84 expected and revenue of $164.27 million compared with the $160.02 million consensus estimate.
  • The stock opened at $43.38, near its 12-month high of $45.28, while analysts maintained a consensus “Hold” rating and an average price target of $42.00. Institutional investors own approximately 81.24% of the company.

IBEX Limited (NASDAQ:IBEX - Get Free Report) CEO Robert Dechant sold 5,000 shares of the company's stock in a transaction that occurred on Friday, September 25th. The stock was sold at an average price of $45.02, for a total transaction of $225,100.00. Following the completion of the transaction, the chief executive officer owned 257,011 shares in the company, valued at approximately $11,570,635.22. This represents a 1.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Robert Thomas Dechant also recently made the following trade(s):

  • On Tuesday, September 15th, Robert Dechant sold 25,000 shares of IBEX stock. The shares were sold at an average price of $39.99, for a total transaction of $999,750.00.

IBEX Trading Down 2.1%

IBEX stock opened at $43.38 on Wednesday. The company has a market capitalization of $576.09 million, a PE ratio of 13.86 and a beta of 0.72. IBEX Limited has a 12-month low of $25.94 and a 12-month high of $45.28. The business's fifty day moving average price is $37.84 and its 200 day moving average price is $32.87.




IBEX (NASDAQ:IBEX - Get Free Report) last posted its earnings results on Friday, September 11th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.01. The firm had revenue of $164.27 million for the quarter, compared to analyst estimates of $160.02 million. IBEX had a return on equity of 28.96% and a net margin of 7.19%.

Analyst Upgrades and Downgrades

Several research firms have commented on IBEX. Wall Street Zen downgraded shares of IBEX from a "strong-buy" rating to a "buy" rating in a research note on Saturday, September 12th. Weiss Ratings upgraded IBEX from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Monday, September 21st. Finally, Robert W. Baird lifted their target price on IBEX from $40.00 to $44.00 and gave the company a "neutral" rating in a report on Monday. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, IBEX has a consensus rating of "Hold" and an average target price of $42.00.

Read Our Latest Stock Analysis on IBEX

Institutional Trading of IBEX

Several hedge funds have recently added to or reduced their stakes in IBEX. Tieton Capital Management LLC purchased a new stake in shares of IBEX in the 2nd quarter valued at approximately $8,353,000. Globeflex Capital L P acquired a new stake in shares of IBEX in the 2nd quarter valued at $3,112,000. Y Intercept Hong Kong Ltd lifted its position in shares of IBEX by 121.8% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 95,665 shares of the company's stock worth $2,566,000 after purchasing an additional 52,526 shares during the last quarter. Lazard Asset Management LLC lifted its position in shares of IBEX by 55.2% during the 1st quarter. Lazard Asset Management LLC now owns 89,150 shares of the company's stock worth $2,391,000 after purchasing an additional 31,697 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of IBEX by 7.5% during the first quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company's stock worth $9,607,000 after purchasing an additional 24,942 shares in the last quarter. Institutional investors and hedge funds own 81.24% of the company's stock.

About IBEX

(Get Free Report)

IBEX Limited (NASDAQ: IBEX) is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.

The company's services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.

IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.

Featured Articles

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at IBEX?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for IBEX and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles